Name: Latest research reports of Alembic Pharmaceuticals Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alembic Pharmaceuticals Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Slowing Down Stock

846.1500 9.50 (1.14%)

NSE Dec 31, 2025 15:53 PM

Volume: 37,544

Alembic Pharmaceuticals Ltd.

09 May 2024

846.15

1.14%

Alembic Pharma (HOLD): Strong margins; positives priced in

Hold: Alembic Pharmaceuticals Ltd.

BOB Capital Markets Ltd.

ALPM reported strong margin gains in Q4 on account of better utilisation of new facilities and traction in the US business

Alembic Pharmaceutic.. has an average target of 1028.50 from 4 brokers.